These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29074831)

  • 1. [Update on recent progress in vitamin D research. Eldecalcitol and intestinal calcium absorption.].
    Uenishi K; Shiraki M
    Clin Calcium; 2017; 27(11):1587-1594. PubMed ID: 29074831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Frontiers in vitamin D; basic research and clinical application. Eldecalcitol: the effect on bones and calcium metabolism].
    Endo I; Matsumoto T
    Clin Calcium; 2011 Nov; 21(11):103-10. PubMed ID: 22040826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vitamin D analog 1α,25-Dihydroxy-2β-(3-Hydroxypropyloxy) vitamin D(3) (Eldecalcitol) is a potent regulator of calcium and phosphate metabolism.
    Brown AJ; Ritter CS
    Calcif Tissue Int; 2011 Nov; 89(5):372-8. PubMed ID: 21912832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eldecalcitol is more effective in promoting osteogenesis than alfacalcidol in Cyp27b1-knockout mice.
    Hirota Y; Nakagawa K; Isomoto K; Sakaki T; Kubodera N; Kamao M; Osakabe N; Suhara Y; Okano T
    PLoS One; 2018; 13(10):e0199856. PubMed ID: 30281599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eldecalcitol for the treatment of osteoporosis.
    Noguchi Y; Kawate H; Nomura M; Takayanagi R
    Clin Interv Aging; 2013; 8():1313-21. PubMed ID: 24101867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of eldecalcitol and alfacalcidol on bone and calcium metabolism.
    Matsumoto T; Takano T; Yamakido S; Takahashi F; Tsuji N
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):261-4. PubMed ID: 20298784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eldecalcitol: a review of its use in the treatment of osteoporosis.
    Sanford M; McCormack PL
    Drugs; 2011 Sep; 71(13):1755-70. PubMed ID: 21902297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eldecalcitol and calcitriol stimulates 'bone minimodeling,' focal bone formation without prior bone resorption, in rat trabecular bone.
    Saito H; Takeda S; Amizuka N
    J Steroid Biochem Mol Biol; 2013 Jul; 136():178-82. PubMed ID: 23069645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of vitamin D, its metabolites, and analogs in the management of osteoporosis.
    Bikle DD
    Rheum Dis Clin North Am; 1994 Aug; 20(3):759-75. PubMed ID: 7984788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eldecalcitol for the treatment of osteoporosis.
    Matsumoto T; Endo I
    Drugs Today (Barc); 2012 Mar; 48(3):189-96. PubMed ID: 22462038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional and potent roles of the 3-hydroxypropoxy group provide eldecalcitol's benefit in osteoporosis treatment.
    Ono Y
    J Steroid Biochem Mol Biol; 2014 Jan; 139():88-97. PubMed ID: 24139874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eldecalcitol: newly developed active vitamin D(3) analog for the treatment of osteoporosis.
    Hagino H
    Expert Opin Pharmacother; 2013 Apr; 14(6):817-25. PubMed ID: 23477453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eldecalcitol replaces endogenous calcitriol but does not fully compensate for its action in vivo.
    Saito H; Harada S
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():189-96. PubMed ID: 24291401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone effects of vitamin D - Discrepancies between in vivo and in vitro studies.
    Suda T; Takahashi F; Takahashi N
    Arch Biochem Biophys; 2012 Jul; 523(1):22-9. PubMed ID: 22107950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of inhibitory action of eldecalcitol, an active vitamin D analog, on bone resorption in vivo.
    Takahashi N
    J Steroid Biochem Mol Biol; 2013 Jul; 136():171-4. PubMed ID: 23220095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eldecalcitol reduces osteoporotic fractures by unique mechanisms.
    Kondo S; Takano T; Ono Y; Saito H; Matsumoto T
    J Steroid Biochem Mol Biol; 2015 Apr; 148():232-8. PubMed ID: 25625663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D analogs and bone: preclinical and clinical studies with eldecalcitol.
    Matsumoto T; Takano T; Saito H; Takahashi F
    Bonekey Rep; 2014; 3():513. PubMed ID: 24818005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frontiers in vitamin D; Basic research and clinical application. The effects of eldecalcitol on bone mineral density and fracture prevention--Post hoc analysis].
    Hagino H
    Clin Calcium; 2011 Nov; 21(11):111-8. PubMed ID: 22040827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current Topics on Vitamin D. Treatment of osteoporosis with eldecalcitol: Its therapeutic efficacy and adverse effect on renal function].
    Takeuchi Y
    Clin Calcium; 2015 Mar; 25(3):425-32. PubMed ID: 25716816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Frontiers in vitamin D; basic research and clinical application. Inhibitory effects of eldecalcitol, an active vitamin D derivative, on bone resorption in vivo].
    Harada S; Mizoguchi T; Takahashi N
    Clin Calcium; 2011 Nov; 21(11):91-8. PubMed ID: 22040825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.